The Complete List and Analysis of the Best Pharmaceutical Companies for Oncology in 2017
The global cancer therapeutics market in 2017 was estimated at USD 121 billion and projected to reach USD 172.6 billion by 2022. The top 10 oncology drugs accounted for revenue of USD 54.48 billion in 2017. Celgene, dominates the oncology market, with its best-selling product, Revlimid.
Sources: SEC filings, companies websites, and annual reports.Top 10 Pharmaceutical Companies 2018 – Oncology last edit: 2018-06-27T20:29:37+00:00 da